Corrigendum to "Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine" [J Hepatol (2023) 937-946]

Affiliations

• ¹ Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, F-75018 Paris, France. Electronic address: [email protected].
• ² MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.
• ³ Population Health Sciences, University of Bristol Medical School, Bristol, UK.
• ⁴ Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
• ⁵ Department of Paediatrics and the Clinical Research Center, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
• ⁶ MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK; Institute for Global Health, University College London, London, UK.
• ⁷ Département de Santé Publique/Pôle Référence Hépatite C, CHU Nice, Nice, France.
• ⁸ Department of Paediatric Infectious Diseases and Paediatric Immunology, Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
• ⁹ Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, F-75018 Paris, France; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, F-75018 Paris, France.
• ¹⁰ Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, F-75018 Paris, France. Electronic address: [email protected].